There have been major gains in the field of cancer research with the development of biotherapeutic antibodies, peptides, and small-molecule agents that specifically inhibit oncoproteins or major signaling nodes that drive tumorigenesis.
The ability to produce highly purified target-specific antibodies has made it possible to detect, quantify, and observe the ways in which specific proteins function within tissue, cells, and extracellular compartments.
The role of research antibodies in basic and translational research cannot be overstated. A wide range of experimental techniques, including western blot, immunofluorescence analysis, flow cytometry, enzyme-linked immunosorbent assay (ELISA), Luminex™ assays, and other tools, that utilize research antibodies are regularly used to research targets associated with cancer biology.
By downloading a copy of Thermo Fisher Scientific’s 75-page cancer research handbook, “Exploring cancer proliferative signaling pathways” you will:
- Learn about the major milestones in the study of cancer proliferative signaling
- Discover how advances in cancer research have enabled practical applications in targeted cancer cell therapy
- Gain access to detailed protocols for a wide range of experimental techniques
- Find the right mix of tools and technologies to advance your research
Download your FREE copy of “Exploring cancer proliferative signaling pathways” today!